OFFICIAL STOCK MARKET AND ECONOMY THREAD VOL. A NEW CHAPTER

ROKU calls ******* up my whole week as if I didn’t have
5 successful trade within these three days :smh: :smh: :smh:

that’s why risk management is important for a trader just imagine if I went all in and it was my first trade of the week:smh::smh::angry:
 
Well, my Roth will be very happy tomorrow. AAPL better continue this win streak for the market, but not optimistic.
 
God bless these earnings. Started positions in dis,work, AYX, estc and DDOG. Very small positions to start and plan on dca’ing on dips. Also have limit buys set up in jnj for 139, lvgo at 31.77. Looking to build the portfolio around high growth stocks and dividend plays that provide earnings growth. Plan on adding Apple on any dip back under 230 and sbux under 60. We’ll see what happens with time.
 
We will NEVER GO DOWN.
*est2009

Scary thing is the FED still has ammo left...Neg Rates & Direct Purchases and already QEternity.
 
No way Fed will move to buy equities IMO but time will tell.

Still have some cash on the sidelines, probably won't buy until we see a substantial dip. Feel like might be better used towards a home down payment at this point
 
51% or w.e it is in decreased duration of symptoms is actually a solid number when it comes to antiviral medications. The problem is, according to the data, we don’t know if it’s the actual drug that’s improving symptoms or the patients immune system. Statistically they weren’t able to prove that. In simplified short terms the p value is really all you need to look at it in clinical trials. Ofcourse Gilead will push it, theyre a billionaire pharmaceutical company.
Why wouldn’t you compare it to the control group though, the number that matters is it’s success rate relative to the control
 
Why wouldn’t you compare it to the control group though, the number that matters is it’s success rate relative to the control

You would think that thats what matters. Not how clinical trials and scientific data works though. If 50% of people take a sugar pill and the other 50% take Remdesivir and both of their outcomes are exactly the same, then that doesn’t prove anything. A lot of drug trials have plenty of results like this but never get approved because there is no statistical significance in what they are testing. They have to prove that that the hypothesis is null.

If the results are not statistically significant as a cure/treatment/mortality benefit then it’s a wash. Right now people are desperate for a treatment and every pharmaceutical company is rushing for one, so anything will be news.

Big companies will bend the news and involve heavy bias in their trials. Look at how Viagra was first approved by Pfizer. A lot of people (~60 %) that were receiving a placebo still achieved a full erection, that drugs trials were terrible yet they still made millions off it.
 
You would think that thats what matters. Not how clinical trials and scientific data works though. If 50% of people take a sugar pill and the other 50% take Remdesivir and both of their outcomes are exactly the same, then that doesn’t prove anything. A lot of drug trials have plenty of results like this but never get approved because there is no statistical significance in what they are testing. They have to prove that that the hypothesis is null.

If the results are not statistically significant as a cure/treatment/mortality benefit then it’s a wash. Right now people are desperate for a treatment and every pharmaceutical company is rushing for one, so anything will be news.

Big companies will bend the news and involve heavy bias in their trials. Look at how Viagra was first approved by Pfizer. A lot of people (~60 %) that were receiving a placebo still achieved a full erection, that drugs trials were terrible yet they still made millions off it.
Ehhh your memory is off on the sildenafil/viagra study. I won’t derail the thread on it but if you check out the trial, the results were significant vs placebo.

I checked out the Gilead results for remdesivir and it showed a 31% faster recovery time vs placebo (11 days vs 15 days). The remdesivir group mortality rate was 8% vs 11.6% placebo.
 
None of it is statistically significant. That’s the point for every trial. If we were going based on that almost every drug would be approved after a phase iii trial.
 
Who's still holding into them shorts 8o

I truly don't understand and have moved to an overweight cash position. Not willing to go short, but as far as I'm concerned holding cash is a short play.
 
Who's still holding into them shorts :nerd:

I truly don't understand and have moved to an overweight cash position. Not willing to go short, but as far as I'm concerned holding cash is a short play.
I've got an open put option on SPY with 10/16 expiration. No way this market survives halfway thru Q3, so my Q4 play is sitting and waiting. Might add more if the market keeps rising.
 
Even if we reopen and you have to put restrictions on crowd sizes people are better off closing to save money than lose money on being half open and paying employees and rent
 
Recovery time reached statistical significance

Mortality rate did not

Ok just looked through it. They hit significance on one point, 31% in the improvement of symptoms. That's not a bad number. Tamiflu, the drug approved for influenza, wasnt far off and it flies off the shelves at the pharmacy.

On the other hand, my hospital had patients in the trial, lets just say a lot of the doctors were severely underwhelmed by the results they were seeing. Still waiting on access for the full article once that comes out. If the trial was sponsored by the pharmaceutical company itself (Gilead), that would tell you enough about the bias involved. If they approve this, it would be an act of desperation and false hope.

Tocilizumab (Actemra) shows much more promise from my actual patient experience.
 
Who's still holding into them shorts :nerd:

I truly don't understand and have moved to an overweight cash position. Not willing to go short, but as far as I'm concerned holding cash is a short play.

Started shorting again today but otherwise heavily in cash. This market is total BS... most ridiculous fraud and manipulation i’ve ever seen. I’ll gladly “miss the rally” than buy in at these levels.
 
Who's still holding into them shorts :nerd:

I truly don't understand and have moved to an overweight cash position. Not willing to go short, but as far as I'm concerned holding cash is a short play.

I'm still short and in the house of pain. The market just keeps going higher and higher every day. Tomorrow I'm expecting another big up day after the unemployment claims come out. Anything under 10 million is bullish.
 
I'm still short and in the house of pain. The market just keeps going higher and higher every day. Tomorrow I'm expecting another big up day after the unemployment claims come out. Anything under 10 million is bullish.
Higher unemployment means higher stock valuations 8) When we hit 50 million unemployment claims, we hit DOW 50,000 :hat
 
Back
Top Bottom